Takeda   Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Osaka Japan (1781)

Organization Overview

First Clinical Trial
1996
NCT00817739
First Marketed Drug
1988
cefotiam (ceradon)
First NDA Approval
1988
cefotiam (ceradon)
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Laboratoires Takeda | Millennium Pharmaceuticals, Inc. | Millennium: The Takeda Oncology Company | PT. Takeda Indonesia | Takeda | TAKEDA | Takeda Bio Development Center, Ltd | Takeda Canada, Inc. | Takeda China (for the BP lowering arm of the study in China, from March 2016) | Takeda Development Center Americas | Takeda Development Center Americas, Inc. | Takeda Development Center Americas (TDCA) | Takeda Development Center Asia, Pte Ltd. | Takeda Global Research and Development | Takeda Global Research and Development Center, Inc. | Takeda Global Research and Developmnet Center Inc | Takeda Global Research & Development Center | Takeda Global Research & Development Center (Europe), Ltd. | Takeda Global Research & Development Centre (Europe) | Takeda Italia Farmaceutici SpA | Takeda Kasei | Takeda Nycomed | Takeda Pharma | Takeda Pharmaceutical Company Limited (Japan) | Takeda Pharmaceuticals Company Limited | Takeda Pharmaceuticals Company Ltd. | Takeda Pharmaceuticals International, Inc. | Takeda Pharmaceuticals Limited | Takeda Pharmaceuticals North America, Inc. | Takeda Pharma Gmbh, Aachen (Germany) | Takeda Pharma GmbH, Aachen (Germany) | Takeda Pharma GmbH (Germany) | TAKEDA PHARMS NA | TAKEDA PHARMS USA | Todd Doyle